NATURE REVIEWS UROLOGY[ta] - Search Results

Year	Number of Results
2009	99
2010	182
2011	226
2012	204
2013	257
2014	292
2015	275
2016	294
2017	262
2018	197
2019	148
2020	146
2021	145
2022	148
2023	164
2024	81

1

Current and emerging treatment options for premature ejaculation.

Gul M, Bocu K, Serefoglu EC. Gul M, et al. Nat Rev Urol. 2022 Nov;19(11):659-680. doi: 10.1038/s41585-022-00639-5. Epub 2022 Aug 25. Nat Rev Urol. 2022. PMID: 36008555 Review.

2

Epidemiology, definition and treatment of complicated urinary tract infections.

Wagenlehner FME, Bjerklund Johansen TE, Cai T, Koves B, Kranz J, Pilatz A, Tandogdu Z. Wagenlehner FME, et al. Nat Rev Urol. 2020 Oct;17(10):586-600. doi: 10.1038/s41585-020-0362-4. Epub 2020 Aug 25. Nat Rev Urol. 2020. PMID: 32843751 Review.

3

Genetics of kidney stone disease.

Howles SA, Thakker RV. Howles SA, et al. Nat Rev Urol. 2020 Jul;17(7):407-421. doi: 10.1038/s41585-020-0332-x. Epub 2020 Jun 12. Nat Rev Urol. 2020. PMID: 32533118 Review.

4

Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective.

Teoh JY, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M. Teoh JY, et al. Nat Rev Urol. 2022 May;19(5):280-294. doi: 10.1038/s41585-022-00578-1. Epub 2022 Mar 31. Nat Rev Urol. 2022. PMID: 35361927 Review.

5

Mechanisms of the intestinal and urinary microbiome in kidney stone disease.

Miller AW, Penniston KL, Fitzpatrick K, Agudelo J, Tasian G, Lange D. Miller AW, et al. Nat Rev Urol. 2022 Dec;19(12):695-707. doi: 10.1038/s41585-022-00647-5. Epub 2022 Sep 20. Nat Rev Urol. 2022. PMID: 36127409 Review.

6

Defining cisplatin eligibility in patients with muscle-invasive bladder cancer.

Jiang DM, Gupta S, Kitchlu A, Meraz-Munoz A, North SA, Alimohamed NS, Blais N, Sridhar SS. Jiang DM, et al. Nat Rev Urol. 2021 Feb;18(2):104-114. doi: 10.1038/s41585-020-00404-6. Epub 2021 Jan 11. Nat Rev Urol. 2021. PMID: 33432181 Review.

7

The biology and rationale of targeting nectin-4 in urothelial carcinoma.

Heath EI, Rosenberg JE. Heath EI, et al. Nat Rev Urol. 2021 Feb;18(2):93-103. doi: 10.1038/s41585-020-00394-5. Epub 2020 Nov 25. Nat Rev Urol. 2021. PMID: 33239713 Review.

8

Genetic control of typical and atypical sex development.

Reyes AP, León NY, Frost ER, Harley VR. Reyes AP, et al. Nat Rev Urol. 2023 Jul;20(7):434-451. doi: 10.1038/s41585-023-00754-x. Epub 2023 Apr 5. Nat Rev Urol. 2023. PMID: 37020056 Review.

9

Preoperative exercise interventions to optimize continence outcomes following radical prostatectomy.

Mungovan SF, Carlsson SV, Gass GC, Graham PL, Sandhu JS, Akin O, Scardino PT, Eastham JA, Patel MI. Mungovan SF, et al. Nat Rev Urol. 2021 May;18(5):259-281. doi: 10.1038/s41585-021-00445-5. Epub 2021 Apr 8. Nat Rev Urol. 2021. PMID: 33833445 Free PMC article. Review.

10

Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma.

Rosellini M, Marchetti A, Mollica V, Rizzo A, Santoni M, Massari F. Rosellini M, et al. Nat Rev Urol. 2023 Mar;20(3):133-157. doi: 10.1038/s41585-022-00676-0. Epub 2022 Nov 21. Nat Rev Urol. 2023. PMID: 36414800 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,867 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,867 results

Results by year